News Abbott India Limited

Equities

ABBOTINDIA

INE358A01014

Pharmaceuticals

Delayed Bombay S.E. Other stock markets 01:45:54 11/07/2025 pm IST			5-day change	1st Jan Change
34,435.05 ^INR	-0.51%		-2.95%	+15.76%

15/05	Abbott India's quarterly profit climbs 28% on strong demand	RE
15/05	Abbott India Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025	CI

Abbott India's quarterly profit climbs 28% on strong demand	15/05	RE
Abbott India Reports Q4 Profit Of 3.67 Billion Rupees	15/05	RE
Abbott India Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025	15/05	CI
Abbott India Limited announces Annual dividend, payable on September 12, 2025	15/05	CI
Abbott India Says Swati Dalal Resigns As Managing Director	07/05	RE
Abbott India Limited Announces Resignation of Swati Dalal as Managing Director, Effective June 13, 2025	07/05	CI
Abbott India Limited Announces Resignation of Swati Dalal as Director and Key Managerial Personnel, Effective June 13, 2025	07/05	CI
Abbott India Appoints Maithilee Mistry As CFO	18/04	RE
Abbott India Limited Appoints Maithilee Mistry as the Chief Financial Officer, Effective May 6, 2025	18/04	CI
Abbott India Limited Appoints Maithilee Mistry as the Key Managerial Personnel, Effective May 6, 2025	18/04	CI
Abbott India Limited Announces the Resignation of Ms. Namita Shah - Associate Director -New Product Introduction and Therapy Area Strategy of the Company, Effective from April 15, 2025	16/04	CI
Abbott India hits all-time high on robust Q3 25 performance	04/04
Abbott India Limited Appoints Devesh Choudhari as Director - Finance, Effective April 1, 2025	01/04	CI
Abbott India Limited Announces Resignation of Jyoti Saraph, Director Finance, with Effect from June 23, 2025	26/03	CI
Abbott India Limited Announces Resignation of Namita Shah - Associate Director - New Product Introduction and Therapy Area Strategy, Effective April 15, 2025	20/02	CI
Abbott India posts higher Q3 profit on strong demand	05/02	RE
Abbott India Q3 Profit 3.61 Bln Rupees	05/02	RE
Abbott India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	05/02	CI
Abbott India Limited Approves the Appointment of Harshraj Madan as Commercial Director - GI Business, Effective February 17, 2025	05/02	CI
Abbott India Limited Announces Board Changes	03/02	CI
Abbott India Limited Announces Kunal Chowdhury - Commercial Director - GI Businesses, to Serve Until January 31, 2025	21/01	CI
Abbott India Limited Appoints Anuj Mehra as Commercial Director - Neurolife, Gennext and Vaccines, Effective February 1, 2025	16/01	CI
Abbott India Limited Announces Change of Commercial Director	03/01	CI
Abbott India's CFO Steps Down	17/12	MT
Abbott India Limited Announces Resignation of Sridhar Kadangode as Whole Time Director and Director	16/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Abbott India hits all-time high on robust Q3 25 performance

April 04, 2025 at 04:27 pm IST